Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrit... ( China represents the largest single m...)

Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market

Date:8/16/2011

China represents the largest single market growth opportunity in global nutrition. Abbott expects to increase its nutrition revenues in China to more than $1 billion (USD) by the end of 2014. China also continues to be an important part of Abbott's emerging markets strategy. In the first half of the year, more than 26 percent of Abbott's global sales were in emerging markets and nearly 42 percent of Abbott Nutrition's global sales were in emerging markets.

When completed, the plant will become Abbott's first fully integrated spray drying, blending and packaging facility in China. The company's new facility will be located in the Jiaxing Economic and Technological Development Zone, which is located mid-way between Shanghai and Hangzhou.

Abbott's Commitment in China

Abbott has been operating in China for nearly 20 years and currently has more than 3,000 employees in the country. Abbott is one of the leading companies in China in the area of social responsibility. The company has been named to the top 100 ranking by both The China Corporate Social Responsibility List and the Southern Weekly List for its outstanding corporate citizenship work and for its long-term commitment to philanthropy. Abbott led the way in several categories including environmental management and climate strategy, business practices, supplier standards and innovative philanthropy.

About Abbott Nutrition

For more than 85 years, Abbott Nutrition has been developing and marketing science-based nutritional products to support the growth, health and wellness of people of all ages. Internationally recognized brands include the Similac® brand of infant formulas; the Gain® brand of growing-up milks; the PediaSure® line of nutritionals for children; and the Ensure® brand of complete and balanced nutrition for adults.

The company is a leader in nutritional products clinically shown to address the disti
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Perdue Kidd & Vickery Files Lawsuit Against Abbott Laboratories for Inadequate Leukemia and Cancer Warning
2. Abbotts HIV Combo Test Detects Infections Earlier, Provides Valuable Information to Help Prevent Further HIV Transmission and May Save Treatment Costs
3. Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
4. Study Shows Improved Patient Management and Outcome Using Abbotts Sensitive Troponin Assay
5. Data From Landmark Clinical Trial of Abbotts MitraClip® System Demonstrate Durable Clinical Benefits for Patients With Mitral Regurgitation Two Years After Treatment
6. FDA Clears Abbotts i-STAT® 1 Wireless Point of Care Testing System
7. Abbotts Ibis Technology Identified Fatal Disease Organism in Afghanistan
8. Abbott Introduces Biothreat Assay for PLEX-ID™ System
9. Intelligent Medical Devices, Inc. (IMDx) Enters into an Agreement with Abbott for the Distribution of a Broad Menu of Molecular Tests
10. Partners In Health, Abbott and the Abbott Fund Unite to Combat Severe Childhood Malnutrition in Haiti
11. AstraZeneca and Abbott End License Agreement for the Development of CERTRIAD

Post Your Comments:

(Date:7/24/2014)... -- Uroplasty, Inc. (NASDAQ: UPI ), a medical ... proprietary products to treat voiding dysfunctions, today reported ... ended June 30, 2014. Global revenue for ... 19% to $4.1 million, as compared to $3.4 ... year. Total revenue for the fiscal first quarter ...

(Date:7/24/2014)... July 24, 2014 Mettler-Toledo International Inc. (NYSE: ... 2014. Provided below are the highlights: , ... quarter compared with the prior year. Reported sales increased ... , Net earnings per diluted share as reported (EPS) ... of 2013. Adjusted EPS was $2.57, an increase of ...

(Date:7/24/2014)... 24, 2014 Amgen (NASDAQ: AMGN ) ... results on Tuesday, July 29, 2014, after the close of ... a conference call with the investment community at 2 p.m. ... Robert A. Bradway , chairman and chief executive officer, and ... audio of the conference call will be simultaneously broadcast over ...

[0] Uroplasty Reports Fiscal First Quarter Results [0] Mettler-Toledo International Inc. Reports Second Quarter 2014 Results [0] Amgen Announces Webcast of 2014 Second Quarter Financial Results

... March 12 Genta,Incorporated (Nasdaq: GNTA ) today announced ... 31, 2007. The Company noted,significant recent milestones, including:, ... biomarker initiates in melanoma -- New oral product, ... 505(b)(2) strategy -- Tesetaxel, a leading ...

... Achieve Weight Loss with Education & ... ... Findings in the Journal of,the American Medical Association on the largest ... prevention.,The combination of both personal contact and web-based support are,identified as ...

Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights Study Finds Personal and Web-Based Support Equal Weight Loss Success

(Date:7/25/2014)... be treated more quickly after Manchester research , ... blood test on arrival, is effective in reducing ... study shows., The findings of a research group ... could potentially make a huge difference to a ... most common reason for emergency hospital admission. In ...

(Date:7/25/2014)... some patients is real and is only natural. However, ... in Cancer , the incidence and effects of ... computed tomography (CT) lung cancer screening exams are far ... , "Unsubstantiated claims of systemic and harmful patient ... continue to delay implementation of CT lung cancer screening ...

(Date:7/25/2014)... Ross A. Clevens, MD, FACS, and ... join the exclusive Obagi Clinical Advisory Board, comprised of ... plastic surgeons and dermatologists. , Dr. Clevens recently ... of thought leaders held its first meeting in three ... give Obagi the opportunity to meet with eight of ...

(Date:7/25/2014)... A report released by the Juvenile Diabetes ... 2013 (July 1, 2012- June 30, 2013). , Outside of ... is the largest single funder of type 1 diabetes research ... with most of the top research centers. There is ... 1 diabetes in the near future. , Since the 2008 ...

(Date:7/25/2014)... HealthDay Reporter , THURSDAY, July ... girls and boys are getting the human papillomavirus (HPV) vaccine, ... officials said Thursday. The U.S. Centers for Disease Control ... 12 get the three-dose vaccine so that protection is in ... Yet, despite a slight increase over the year before, only ...

Breaking Medicine News(10 mins):Health News:Heart attack patients could be treated more quickly after Manchester research 2 Health News:ACR statement on cancer study regarding patient anxiety from CT lung cancer screening 2 Health News:Renowned Melbourne Plastic Surgeon to Join Private Medical Advisory Board 2 Health News:Report: JDRF 2013 Annual Research Spending Down by $50 million 2 Health News:Too Few Teens Receive HPV Shot, CDC Says 2 Health News:Too Few Teens Receive HPV Shot, CDC Says 3

[0] Heart attack patients could be treated more quickly after Manchester research [0] ACR statement on cancer study regarding patient anxiety from CT lung cancer screening [0] Renowned Melbourne Plastic Surgeon to Join Private Medical Advisory Board [0] Report: JDRF 2013 Annual Research Spending Down by $50 million [0] Too Few Teens Receive HPV Shot, CDC Says

... George Dahlman, senior vice president of public policy for ... the U.S. Senate Subcommittee on Defense Appropriations, calling for ... at the Department of Defense (DoD). , , ... blood cancers, including chronic lymphocytic leukemia (CLL), lymphoma and ...

... ... DIA Meeting in San Diego, Calif. , ... Boston, Mass. (PRWEB) June 18, 2009 -- CenterWatch , ... annual surveys aimed at better understanding physician referrals to clinical trials and study volunteer ...

... healthcare alliance Innovation Celebration , , ANAHEIM, Calif., June ... medical devices SpA, Italy, yesterday introduced a new innovation in ... fit in the palm of a hand, can record a ... the thumbs. , , The ecg@home(TM) debuted at ...

... June 18 Vendormate, the market leader in vendor ... the role of president, effective immediately. Andy Monin, ... and developing strategic opportunities. , ... success of Vendormate, steadily guiding our processes, systems, and ...

... effect on relationships and lead to significant changes in how ... and emotional level, according a study in the June issue ... from Northern Ireland have come up with four key recommendations ... nine males and seven females, aged between 33 and 78. ...

... - 2009 rankings include 10 specialties and Honor Roll - ... Group today released its second annual rankings by specialty of ... and featured in the August issue of ... July 21. , , The 2009 America,s Best ...

Cached Medicine News:Health News:The Leukemia & Lymphoma Society Calls for Blood Cancer Research Program at the Department of Defense 2 Health News:CenterWatch to Introduce Key Findings from Surveys on Physician Referrals to Clinical Trials and Clinical Trial Volunteer Experiences at DIA Meeting 2 Health News:HealthFrontier Introduces New Innovation in Web-Based Remote Health Monitoring Technology 2 Health News:Bill Hayes Promoted to President of Vendormate 2 Health News:Stroke survivors report loss of sexual desire, blurred gender roles, anger and fatigue 2 Health News:Stroke survivors report loss of sexual desire, blurred gender roles, anger and fatigue 3 Health News:Stroke survivors report loss of sexual desire, blurred gender roles, anger and fatigue 4 Health News:U.S. News Media Group Releases Rankings of America's Best Children's Hospitals 2 Health News:U.S. News Media Group Releases Rankings of America's Best Children's Hospitals 3

The Leukemia & Lymphoma Society Calls for Blood Cancer Research Program at the Department of Defense CenterWatch to Introduce Key Findings from Surveys on Physician Referrals to Clinical Trials and Clinical Trial Volunteer Experiences at DIA Meeting HealthFrontier Introduces New Innovation in Web-Based Remote Health Monitoring Technology Bill Hayes Promoted to President of Vendormate Stroke survivors report loss of sexual desire, blurred gender roles, anger and fatigue U.S. News Media Group Releases Rankings of America's Best Children's Hospitals

... ophthalmic solution is an anti-infective ... doctor may instruct you to ... eye infection caused by bacteria. ... are the 2 types of ...

ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....

ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.15% is medication in the form of an eye drop that is used to lower the pressure inside your eye(s), also referred to as intraocular pressu...

ALOCRIL® ophthalmic solution is a prescription eye drop for itchy allergy eyes. ALOCRIL® provides control beyond relief by providing continuous symptom control throughout the allergy season....

Medicine Products:

OCUFLOX® 1 mL ALPHAGAN® 5 mL ALPHAGAN® P 10 mL ALOCRIL®